Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer

Journal of Alternative and Complementary Medicine

Volumn 19, Issue 8, 2013, Pages 714-720

  Andersen, M Robyn ^a,b   Sweet, Erin ^c   Lowe, Kimberly A ^a,d   Standish, Leanna J ^c   Drescher, Charles W ^a,e   Goff, Barbara A ^f,g  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BASTYR UNIVERSITY   (United States)

^d Exponent Health Sciences   (United States)

^e Pacific Gynecology Specialists   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALTRETAMINE; ANTHRACYCLINE; ASCORBIC ACID; BETA CAROTENE; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; NAVELBINE; PACLITAXEL; PEMETREXED; RETINOL; SELENIUM; TOPOTECAN; UBIDECARENONE;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SUPPLEMENTATION;

ADMINISTRATION, ORAL; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; QUESTIONNAIRES;

EID: 84881458069     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2012.0295     Document Type: Article

References (19)

1. DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 2002;20(18 Suppl):34S-8S.
2. Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health 2007;7:4
3. Astin JA, Reilly C, Perkins C, Child WL; Susan G. Komen Breast Cancer Foundation. Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. J Soc Integr Oncol 2006;4:157-169.
4. Swisher EM, Cohn DE, Goff BA, et al. Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol 2002;84:363-367.
5. Andersen MR, Sweet E, Lowe K, et al. Potentially dangerous complementary and alternative medince (CAM) use in ovarian cancer patients undergoing surgery. J Gyneco Surg 2012;28:116-120.
6. Werneke U, Earl J, Seydel C, Horn O, et al. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer 2004;90:408-413.
7. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001;286:208-216.
8. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park) 1999;13:1003-1008; discussion 1008, 1011-1012.
9. Pace A, Savarese A, Picardo M, et al. Neuroprotective effect of vitamin E supplementation in patients treated with cis-platin chemotherapy. J Clin Oncol 2003;21:927-931.
10. Ladas E, Kelly K. Integrative Oncology: The Antioxidant Debate. Oxford: Oxford University Press, 2009.
11. Saxena A, Tripathi KP, Roy S, Khan F, Sharma A. Pharma-covigilance: effects of herbal components on human drugs interactions involving cytochrome P450. Bioinformation 2008;3:198-204.
12. Delgoda R, Westlake AC. Herbal interactions involving cy-tochrome p450 enzymes: a mini review. Toxicol Rev 2004;23:239-249.
13. Natural Medicines Comprehensive Database. Stockton, CA: Therapeutic Research Faculty; 2010. Online document at: http://naturaldatabase. therapeuticresearch.com/. Accessed between September and November 2010.
14. National Institutes of Health/NCCAM. 10 most common natural products among adults. 2007. Online document at: http://nccam.nih.gov/news/camstats/2007/ camsurvey fs1.htm.
15. Fer M, Dréano Y, Lucas D, et al. Metabolism of eicosa-pentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 2008;471: 116-125.
16. Yao HT, Chang YW, Lan SJ, et al. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes. Life Sci 2006;79:2432-2440.
17. Argyriou AA, Chroni E, Koutras A, et al. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. J Pain Symptom Manage 2006;32:237-244.
18. Argyriou A, Chroni E, Koutras A, et al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 2006;14:1134-1140.
19. Helyer LK, Chin S, Chui BK, et al. The use of complementary and alternative medicines among patients with locally advanced breast cancer-a descriptive study. BMC Cancer 2006;6:39.